bioAffinity Technologies to present positive research data at CHEST 2026
The company says it will present positive research data on development of a test measuring asthma- and COPD-related lung inflammation and drug-related receptors.
The company says it will present positive research data on development of a test measuring asthma- and COPD-related lung inflammation and drug-related receptors.